Karbicombi (Hydrochlorothiazide, Candesartan Cilexetil)

Karbicombi, a fixed‑dose antihypertensive combination, is used to manage high blood pressure.

• Hypertension: lowers systolic and diastolic blood pressure in adults with essential hypertension.
• Cardiovascular risk reduction: contributes to decreased risk of stroke and heart attack by maintaining target blood pressure.
• Treatment simplification: replaces separate prescriptions of a thiazide diuretic and an ARB, improving adherence.

• Hydrochlorothiazide inhibits sodium‑chloride reabsorption in the distal convoluted tubule, increasing urinary excretion of water and electrolytes, which reduces plasma volume. Candesartan cilexetil is a pro‑drug that is converted to candesartan, an angiotensin II type 1 (AT₁) receptor antagonist; it blocks the vasoconstrictive and aldosterone‑secreting actions of angiotensin II. Together, the diuretic and the ARB lower blood pressure through complementary effects on fluid balance and vascular tone.

Karbicombi may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Dizziness: light‑headedness, especially after the first doses.
• Headache: mild to moderate intensity.
• Increased urination: due to the diuretic component.
• Electrolyte disturbances: such as low potassium or sodium.
• Fatigue: general feeling of tiredness.
• Cough: occasional dry cough.

Serious or Rare Side Effects

• Severe dehydration: marked fluid loss requiring medical attention.
• Hyperkalemia or hypokalemia: dangerous potassium level changes.
• Acute kidney injury: sudden decline in renal function.
• Angioedema: swelling of face, lips, tongue or throat.
• Severe hypotension: dangerously low blood pressure.

Before prescribing Karbicombi, clinicians should consider several precautionary measures to ensure safe use.

• Monitor electrolytes: check serum potassium and sodium regularly.
• Assess renal function: evaluate creatinine clearance before and during therapy.
• Use caution in the elderly: increased sensitivity to blood pressure changes.
• Avoid concurrent use with potassium‑sparing diuretics: risk of hyperkalemia.
• Review NSAID use: may diminish diuretic efficacy and affect renal function.
• Store at room temperature: keep in the original container, protect from moisture and light.

Karbicombi can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

• Aliskiren (in diabetic patients): combined use may increase risk of renal impairment.
• Lithium: diuretic may raise lithium levels, leading to toxicity.
• Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalemia.

Moderate Interactions (Monitor Closely)

• Other antihypertensives: additive blood pressure lowering may require dose adjustment.
• NSAIDs: can reduce diuretic effect and impair renal function.